These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24097130)

  • 1. Indian Supreme Court halts approval of new clinical trials until regulatory framework is set up.
    Bagcchi S
    BMJ; 2013 Oct; 347():f5996. PubMed ID: 24097130
    [No Abstract]   [Full Text] [Related]  

  • 2. Germany opposes EU plans for regulating clinical trials owing to lack of ethical standards.
    Tuffs A
    BMJ; 2012 Oct; 345():e6640. PubMed ID: 23033377
    [No Abstract]   [Full Text] [Related]  

  • 3. Reforming the EU environment for clinical trials: what are the challenges?
    Fears R; Blum HE; Kelleher D; Meunier F; Souhami R
    QJM; 2013 Sep; 106(9):787-9. PubMed ID: 23893498
    [No Abstract]   [Full Text] [Related]  

  • 4. EU directive on clinical trials penalizes small sponsors.
    Meldolesi A
    Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
    [No Abstract]   [Full Text] [Related]  

  • 5. Indian Supreme Court tells government to act on illegal clinical trials.
    Kay M
    BMJ; 2013 Jan; 346():f51. PubMed ID: 23293093
    [No Abstract]   [Full Text] [Related]  

  • 6. Trouble at the office.
    Allison M
    Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797
    [No Abstract]   [Full Text] [Related]  

  • 7. Cautious welcome for FDA pharmacogenomics guidance.
    Katsnelson A;
    Nat Biotechnol; 2005 May; 23(5):510. PubMed ID: 15877053
    [No Abstract]   [Full Text] [Related]  

  • 8. On access and accountability--two Supreme Court rulings on generic drugs.
    Boumil MM; Curfman GD
    N Engl J Med; 2013 Aug; 369(8):696-7. PubMed ID: 23923990
    [No Abstract]   [Full Text] [Related]  

  • 9. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory challenges in the review of data from global clinical trials: the PMDA perspective.
    Asano K; Tanaka A; Sato T; Uyama Y
    Clin Pharmacol Ther; 2013 Aug; 94(2):195-8. PubMed ID: 23872835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients, physicians, and clinical trials: the other side of the coins.
    Abramson SB; Flexner C; Snyderman R; Dieterich DT; Korn D; Temple R; Sherwood L; Goldblatt D
    J Investig Med; 1999 Sep; 47(8):343-57. PubMed ID: 10510587
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug regulation 2056.
    Bezold C; Peck J
    Food Drug Law J; 2005; 60(2):127-36. PubMed ID: 16097091
    [No Abstract]   [Full Text] [Related]  

  • 13. Health rights litigation pushes for accountability in clinical trials in India.
    Terwindt C
    Health Hum Rights; 2014 Dec; 16(2):E84-95. PubMed ID: 25569727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moving goalposts--regulatory oversight of antibacterial drugs.
    Brenner R; Ellis-Grosse EJ; Echols R
    Nat Biotechnol; 2006 Dec; 24(12):1515-20. PubMed ID: 17160053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 16. [Legal liability in clinical trials from the legal-pharmaceutical viewpoint].
    Amon F
    Z Arztl Fortbild (Jena); 1995 Nov; 89(6):638-41. PubMed ID: 8588437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unintended consequences of clinical trials regulations.
    McMahon AD; Conway DI; Macdonald TM; McInnes GT
    PLoS Med; 2009 Nov; 3(11):e1000131. PubMed ID: 19918557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials in India: balancing economic opportunity with the public health context.
    Dandona L
    Natl Med J India; 2006; 19(2):57-9. PubMed ID: 16756189
    [No Abstract]   [Full Text] [Related]  

  • 20. India pressed to relax rules on clinical trials. Drug companies claim changes are essential, but critics fear Indian patients will become guinea pigs.
    Sharma DC
    Lancet; 2004 May; 363(9420):1528-9. PubMed ID: 15139330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.